ŞENDUR, M. A. N. Et Al. 2014. The efficacy of adjuvant trastuzumab in HER-2 positive breast cancer with axillary lymph node metastases according to the treatment duration. CURRENT MEDICAL RESEARCH AND OPINION , vol.30, no.12 , 2535-2542.

ŞENDUR, M. A. N., AKSOY, S., Ozdemir, N. Y., Yazici, O., Zengin, N., & Altundag, K., (2014). The efficacy of adjuvant trastuzumab in HER-2 positive breast cancer with axillary lymph node metastases according to the treatment duration. CURRENT MEDICAL RESEARCH AND OPINION , vol.30, no.12, 2535-2542.

ŞENDUR, MEHMET Et Al. "The efficacy of adjuvant trastuzumab in HER-2 positive breast cancer with axillary lymph node metastases according to the treatment duration," CURRENT MEDICAL RESEARCH AND OPINION , vol.30, no.12, 2535-2542, 2014

ŞENDUR, MEHMET A. Et Al. "The efficacy of adjuvant trastuzumab in HER-2 positive breast cancer with axillary lymph node metastases according to the treatment duration." CURRENT MEDICAL RESEARCH AND OPINION , vol.30, no.12, pp.2535-2542, 2014

ŞENDUR, M. A. N. Et Al. (2014) . "The efficacy of adjuvant trastuzumab in HER-2 positive breast cancer with axillary lymph node metastases according to the treatment duration." CURRENT MEDICAL RESEARCH AND OPINION , vol.30, no.12, pp.2535-2542.

@article{article, author={MEHMET ALİ NAHİT ŞENDUR Et Al. }, title={The efficacy of adjuvant trastuzumab in HER-2 positive breast cancer with axillary lymph node metastases according to the treatment duration}, journal={CURRENT MEDICAL RESEARCH AND OPINION}, year=2014, pages={2535-2542} }